-+ 0.00%
-+ 0.00%
-+ 0.00%

LINEAGE CELL THERAPEUTICS - TO ASSUME CLINICAL DEVELOPMENT COSTS ESTIMATED AT $3.10 MLN THROUGH FEB 2030

Reuters·11/12/2026 21:05:15